In the BioHarmony Drug Report Database
Goprelto, Numbrino (cocaine) is a small molecule pharmaceutical. Cocaine was first approved as Goprelto on 2017-12-14. It is used to treat cough and pain in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter. In addition, it is known to target 5-hydroxytryptamine receptor 3A and soluble acetylcholine receptor. Goprelto’s patent is valid until 2037-02-07 (FDA).
Image (chem structure or protein)